Tackling hypertension via adrenal ablation - the development of novel immunohistochemical ablation biomarkers

2018 
This project has received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (grant agreements n° 637780 and n° 754308. This work was also supported by COST Action TD1301, MiMed.
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    1
    Citations
    NaN
    KQI
    []